bexmarilimab
faron pharmaceuticals
['biomarker', 'bexmarilimab', 'faron']
yesterday we biomarker data at 2022 annual meeting. the data supports our belief that our investigational #immunotherapy #bexmarilimab has the potential to bring the promise of immunotherapy to a much broader patient population. read more here: 
Faron is a clinical stage biopharmaceutical company focused on harnessing the power of the immune system in order to tackle cancer and inflammation.